secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bluejay Diagnostics, Inc. (BJDX)
CIK:        0001704287
Form:       8-K
Filed at:   2024-10-24T23:59:59+00:00
Accession:  0001213900-24-090120
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Bluejay Diagnostics shareholders approve reverse stock split (1:20-1:50 ratio)
------------------------------------------------------------------------------

- 6,958,210 shares present (42.0% quorum) at October 23, 2024 special meeting.
- Proposal passed: 5,358,166 For, 1,487,443 Against, 112,601 Abstain.
- Board retains discretion to select exact ratio (1:20 to 1:50) and timing.
- No decision yet on whether or when to implement the reverse stock split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704287/000121390024090120/0001213900-24-090120-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704287/000121390024090120/ea0218491-8k_bluejay.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-090120

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer